-
Most Recent
Search Results
240 results for ANV
Why Did Annovis Bio (ANVS) Stock Close Up 80% Today?
ANVS stock closed up more than 75% today after Annovis announced encouraging clinical trial results for its Parkinson’s drug, buntanetap.
Annovis Bio (ANVS) Stock Soars 6% on Positive FDA Update
Annovis Bio (ANVS) stock is soaring higher on Thursday following a positive update from the FDA for its buntanetap clinical trial.
ANVS Stock Earnings: Annovis Bio Beats EPS for Q2 2024
ANVS stock results show that Annovis Bio beat analyst estimates for earnings per share the second quarter of 2024.
ANVS Stock Earnings: Annovis Bio Misses EPS for Q4 2023
ANVS stock results show that Annovis Bio missed analyst estimates for earnings per share the fourth quarter of 2023.
ANVS Stock Earnings: Annovis Bio Beats EPS for Q1 2024
ANVS stock results show that Annovis Bio beat analyst estimates for earnings per share the first quarter of 2024.
3 Gold Stocks That Are Breaking Out
Gold stocks are joining what looks to be the first major breakout in precious metals since August. These three stocks in particular look primed to…
Warsh Tapped for Fed Chair – Metals Crash 27%
Kevin Warsh gets the nod for Fed Chair… the market’s reaction… precious metals finally correct – get ready to buy… new data about our ever-expanding…
It’s Over for Bitcoin…for Now
Luke Lango says Bitcoin has hit its Fourth Bust… a “growing consensus” about the government and your wallet… Eric Fry’s pick crushes Nvidia… where to…
Why the Mag 7 Lost $950B in One Week
Last week’s tech chaos explained… why Alphabet and Amazon’s spending shocked Wall Street… the Stage 1 to Stage 2 transition… which stocks face existential threat…
SaaSmageddon Is Here – and Not All Software Stocks Will Survive
An explanation of why software stocks – especially SaaS – are being structurally disrupted by AI, and how investors can identify survivors.
5 Small-Cap Stocks to Buy
Here are five small-cap stocks that are likely to post spectacular earnings results this week.
10 Worst “Strong Sell” Stocks This Week — RDEN MDR ANV and more
This week, these ten stocks have the worst year-to-date performance. Each of these also rates an “F” (“strong sell”) on Portfolio Grader.
10 Worst “Strong Sell” Stocks This Week — ANV CLNE MDR and more
This week, these ten stocks have the worst year-to-date performance. Each of these also rates an “F” (“strong sell”) on Portfolio Grader.
5 Gold Stocks Set to Double in 2010
Gold is the best sector to invest in for 2010, and the five stocks I’m about to share with you are the best ways to…
5 Gold Stocks and ETFs to Buy Now
More traders are looking to hide out in gold thanks to Thursday’s gut-wrenching ride. Here are five gold stocks and ETFs to cash in on…
10 Worst “Strong Sell” Stocks This Week — ANV CLNE MDR and more
This week, these ten stocks have the worst year-to-date performance. Each of these also rates an “F” (“strong sell”) on Portfolio Grader.
Company Layoffs Accelerate While Fed Stays Silent
In this week’s Navellier Market Buzz, I explained the fears behind the recent layoffs, what’s causing the massive trade deficit and why gold could reach…
10 Worst “Strong Sell” Stocks This Week — ANV CDE MDR and more
This week, these ten stocks have the worst year-to-date performance. Each of these also rates an “F” (“strong sell”) on Portfolio Grader.
5 Heavy-Duty Commodity Plays for the Long Term
With dollar likely to stay low, commodity prices should stay high. These companies will prosper in a world of costly commodities.
3 – 10 of 240 results
